BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Tamoxifen, rs4950928, VEGFA, cell-cell adhesion, HIV infection, Embryo)
Bookmark Forward

QuickView for RAD51;jsessionid=54F480AF54FAB0C0E70D0E78BFADF30B;jsessionid=4BC8541B96E7514F467F777CD327422B (gene)


Body Atlas

Most Correlated Tissues

  1. Granulocyte-macrophage progenitor cell of bone marrow
  2. Hematopoietic stem cell of bone marrow
  3. T Lymphocyte (regulatory) of peripheral blood
  4. Colon mucosa
  5. Natural killer cell of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Injury of liver
  2. Platelet count below reference range
  3. Bacterial infection due to Bacillus
  4. Viral infections of the central nervous system
  5. Social environment related disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Antigens, Neoplasm
  2. Maltose
  3. Ciliary Neurotrophic Factor
  4. Ficoll
  5. ioversol
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR124-2
  2. CLOCK
  3. DBI
  4. BLM
  5. SV40_large_T_Ag_specific-S
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Reconstitution of the antagonistic effect between C1orf112/FIRRM-FIGNL1 and BRCA2 on RAD51 filament …
  2. RAD51 and Infertility: A Review and Case-Control Study.
  3. Structure of RADX and mechanism for regulation of RAD51 nucleofilaments.
  4. Human AAA+ ATPase FIGNL1 suppresses RAD51-mediated ultra-fine bridge formation.
  5. Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and pat…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for RAD51;jsessionid=54F480AF54FAB0C0E70D0E78BFADF30B;jsessionid=4BC8541B96E7514F467F777CD327422B
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.